This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2002.
Company Filing History:
1 out of 834,411 Years Active: 2002
Title: Innovations by Alexis Gautreau
Introduction
Alexis Gautreau is an accomplished inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for tumor treatment. His work exemplifies the intersection of science and practical application in medicine.
Latest Patents
Gautreau holds a patent for a pharmaceutical composition containing ezrin mutated on tyrosine 353. This invention relates to a pharmaceutical composition that includes an effective amount of ezrin mutated on tyrosine 353, or a functional fragment or derivative thereof, in association with a pharmaceutically acceptable carrier. The primary use of this composition is in the prevention and/or treatment of tumors. He has 1 patent to his name.
Career Highlights
Throughout his career, Gautreau has focused on advancing medical treatments through innovative research. His dedication to improving patient outcomes is evident in his patent work and ongoing research efforts.
Collaborations
Gautreau has collaborated with notable colleagues, including Monique Arpin and Tiziana Crepaldi. These partnerships have contributed to the development of his innovative pharmaceutical compositions.
Conclusion
Alexis Gautreau's work in pharmaceutical innovation highlights the importance of research in developing effective treatments for serious health conditions. His contributions to the field are noteworthy and reflect a commitment to advancing medical science.